✦ LIBER ✦

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

✍ Scribed by Ronald Christopher; Paul Covington; Michael Davenport; Penny Fleck; Qais A. Mekki; Elisabeth R. Wann; Aziz Karim

Book ID: 116372143
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 267 KB
Volume: 30
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2008.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, pharmacodynamics and t

Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients

✍ T. Heise; E. U. Graefe-Mody; S. Hüttner; A. Ring; D. Trommeshauser; K. A. Dugi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Clinical pharmacokinetics and tolerabili

Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single doses

✍ J. H. G. Jonkman; G. Bianchetti; G. Grasmeijer; B. Oosterhuis; J. F. Thiercelin; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 515 KB

In a double-blind, placebo-controlled, cross-over experiment in 21 healthy male volunteers, aged 19 to 27 y, the pharmacokinetics and tolerance of the new anxiolytic drug alpidem (SL80.0342) and its three major metabolites were studied after single doses of 25, 50, 100 and 200 mg. Plasma concentrati

Pharmacokinetic and Pharmacodynamic Asse

Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects

✍ A. Marie O'Farrell; Andre van Vliet; Khalid Abou Farha; Julie M. Cherrington; Da 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 898 KB

Pharmacokinetic, pharmacodynamic, and ef

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

✍ Bumsup Lee; Lihong Shi; Daniel B. Kassel; Tomoko Asakawa; Koji Takeuchi; Ronald 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 939 KB

Pharmacokinetic, pharmacodynamic, and to

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

✍ Paul Covington; Ronald Christopher; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects

✍ Jasper Dingemanse; Nolan Wood; Karin Jorga; Rolf Kettler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB